, /PRNewswire/ -- The global size is estimated to grow by billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 4.21% during the forecast period.
For more insights on the forecast market size and historic data (2018 - 2022) - In-vitro diagnostics, utilizing technologies such as immunoassay and molecular diagnostics, are gaining momentum in managing and testing for cancer, cardiovascular diseases, and infectious kidney diseases. Advanced treatment care facilitates increased adoption among healthcare providers. For example, Siemens' Xprecia Stride Coagulation Analyzer performs PT/INR tests with high accuracy.
The market for specialty testing, including esoteric, pathology, and genetic testing, is projected to outpace routine diagnostic testing. Laboratories prefer bulk purchases from trusted partners due to the expanding specialty testing market. Key areas include reference and clinical laboratories, medical tests using bodily fluids and tissues, laboratory environments with specialized equipment and techniques, and molecular diagnostics like next-generation sequencing.
Economic factors, such as budget constraints and economic downturns, influence purchasing decisions. Reagents & kits, instruments, software & services, immunodiagnostics, hematology, tissue diagnostics, clinical chemistry, and point-of-care devices are essential components. Rapid diagnostic testing, chronic diseases, preventive care testing, reimbursement scenarios, disease.
